Literature DB >> 2569986

Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions.

B Meister1, S Ceccatelli, T Hökfelt, N E Andén, M Andén, E Theodorsson.   

Abstract

Indirect immunofluorescence histochemistry and receptor autoradiography were used to study the localization of transmitter-/peptide-containing neurons and peptide binding sites in the mediobasal hypothalamus in normal rats and in rats treated neonatally with repeated doses of the neurotoxin monosodium-glutamate (MSG). In the arcuate nucleus, the results showed a virtually complete loss of cell bodies containing immunoreactivity for growth hormone-releasing factor (GRF), galanin (GAL), dynorphin (DYN), enkephalin (ENK), corticotropin-like intermediate peptide (CLIP), neuropeptide Y (NPY), and neuropeptide K (NPK). Tyrosine hydroxylase(TH)-glutamic acid decarboxylase(GAD)-, neurotensin(NT)- and somatostatin(SOM)-immunoreactive (IR) cells were, however, always detected in the ventrally dislocated, dorsomedial division of the arcuate nucleus. In the median eminence, marked decreases in numbers of GAD-, NT-, GAL-, GRF-, DYN-, and ENK-IR fibers were observed. The numbers of TH-, SOM- and NPY-IR fibers were in contrast not or only affected to a very small extent, as revealed with the immunofluorescence technique. Biochemical analysis showed a tendency for MSG to reduce dopamine levels in the median eminence of female rats, whereas no effect was observed in male rats. Autoradiographic studies showed high to moderate NT binding sites, including strong binding over presumably dorsomedial dopamine cells. In MSG-treated rats, there was a marked reduction in GAL binding in the ventromedial nucleus. The findings implicate that most neurons in the ventrolateral and ventromedial arcuate nucleus are sensitive to the toxic effects of MSG, whereas a subpopulation of cells in the dorsomedial division of the arcuate nucleus, including dopamine neurons, are not susceptible to MSG-neurotoxicity. The results indicate, moreover that the very dense TH-IR fiber network in the median eminence predominantly arises from the dorsomedial TH-IR arcuate cells, whereas the GAD-, NT-, GAL-, GRF- and DYN-IR fibers in the median eminence to a large extent arise from the ventrolateral arcuate nucleus. Some ENK- and NPK-positive cells in the arcuate nucleus seem to project to the lateral palisade zone of the median eminence, but most of the ENK-IR fibers in the median eminence, located in the medial palisade zone, seem to primarily originate from an area(s) located outside the arcuate nucleus, presumably the paraventricular nucleus.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569986     DOI: 10.1007/BF00247894

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  124 in total

1.  Fluorescent antibody methods.

Authors:  A H COONS
Journal:  Gen Cytochem Methods       Date:  1958

2.  Comparative topography of dopamine- and tyrosine hydroxylase-immunoreactive neurons in the rat arcuate nucleus.

Authors:  H Okamura; K Kitahama; I Nagatsu; M Geffard
Journal:  Neurosci Lett       Date:  1988-12-19       Impact factor: 3.046

3.  Monosodium glutamate induced lesions of the arcuate nucleus. I. Endocrine deficiency and ultrastructure of the median eminence.

Authors:  M A Holzwarth-McBride; E M Hurst; K M Knigge
Journal:  Anat Rec       Date:  1976-10

4.  Distribution of substance P-like immunoreactivity in the central nervous system of the rat--I. Cell bodies and nerve terminals.

Authors:  A Ljungdahl; T Hökfelt; G Nilsson
Journal:  Neuroscience       Date:  1978       Impact factor: 3.590

5.  Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate.

Authors:  J W Olney
Journal:  Science       Date:  1969-05-09       Impact factor: 47.728

6.  Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line.

Authors:  K A Markey; H Kondo; L Shenkman; M Goldstein
Journal:  Mol Pharmacol       Date:  1980-01       Impact factor: 4.436

7.  The distribution of enkephalin in the mediobasal hypothalamus of the mouse brain: effects of neonatal administration of MSG.

Authors:  M A Romagnano; T L Chafel; W H Pilcher; S A Joseph
Journal:  Brain Res       Date:  1982-03-25       Impact factor: 3.252

8.  Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS.

Authors:  T Melander; T Hökfelt; A Rökaeus; A C Cuello; W H Oertel; A Verhofstad; M Goldstein
Journal:  J Neurosci       Date:  1986-12       Impact factor: 6.167

9.  A delayed LH/FSH rise after gonadectomy and a delayed serum TSH rise after thyroidectomy in monosodium-L-glutamate (MSG)-treated rats.

Authors:  G H Greeley; G F Nicholson; J S Kizer
Journal:  Brain Res       Date:  1980-08-11       Impact factor: 3.252

10.  Monosodium glutamate admlinistration to the newborn reduces reproductive ability in female and male mice.

Authors:  W J Pizzi; J E Barnhart; D J Fanslow
Journal:  Science       Date:  1977-04-22       Impact factor: 47.728

View more
  21 in total

1.  Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia.

Authors:  Teresa M Reyes; Paul E Sawchenko
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

2.  Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice.

Authors:  Sebastien G Bouret; Shin J Draper; Richard B Simerly
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

3.  Effects of the neonatal treatment with monosodium glutamate on myenteric neurons and the intestine wall in the ileum of rats.

Authors:  Angélica Soares; João Paulo Ferreira Schoffen; Elsa Maria De Gouveia; Maria Raquel Marçal Natali
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

Review 4.  Gene expression and chemical diversity in hypothalamic neurosecretory neurons.

Authors:  B Meister
Journal:  Mol Neurobiol       Date:  1993       Impact factor: 5.590

5.  Regulation of neurotransmission in the arcuate nucleus of the rat by different neuropeptide Y receptors.

Authors:  H Rhim; G A Kinney; P J Emmerson; R J Miller
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

6.  Effects of hindbrain melanin-concentrating hormone and neuropeptide Y administration on licking for water, saccharin, and sucrose solutions.

Authors:  John-Paul Baird; Catalina Rios; Jasmine L Loveland; Janine Beck; Alice Tran; Carrie E Mahoney
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-11-07       Impact factor: 3.619

7.  Interleukin-7, a new cytokine targeting the mouse hypothalamic arcuate nucleus: role in body weight and food intake regulation.

Authors:  Laurence Macia; Odile Viltart; Myriam Delacre; Christelle Sachot; Laurent Héliot; James P Di Santo; Isabelle Wolowczuk
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

8.  The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice.

Authors:  C Broberger; J Johansen; C Johansson; M Schalling; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 9.  Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes.

Authors:  Naomi E Rance; Penny A Dacks; Melinda A Mittelman-Smith; Andrej A Romanovsky; Sally J Krajewski-Hall
Journal:  Front Neuroendocrinol       Date:  2013-07-17       Impact factor: 8.606

10.  Association of monosodium glutamate intake with overweight in Chinese adults: the INTERMAP Study.

Authors:  Ka He; Liancheng Zhao; Martha L Daviglus; Alan R Dyer; Linda Van Horn; Daniel Garside; Liguang Zhu; Dongshuang Guo; Yangfeng Wu; Beifan Zhou; Jeremiah Stamler
Journal:  Obesity (Silver Spring)       Date:  2008-05-22       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.